Huons Future Growth

Future criteria checks 1/6

Huons is forecast to grow earnings and revenue by 15.3% and 9.8% per annum respectively. EPS is expected to grow by 20.5% per annum. Return on equity is forecast to be 14.2% in 3 years.

Key information

15.3%

Earnings growth rate

20.5%

EPS growth rate

Pharmaceuticals earnings growth	38.3%
Revenue growth rate	9.8%
Future return on equity	14.2%
Analyst coverage	Low
Last updated	25 Sep 2024

Recent future growth updates

Recent updates

Is Huons Co., Ltd.'s (KOSDAQ:243070) Recent Performance Tethered To Its Attractive Financial Prospects?

Feb 21

What Type Of Shareholders Own The Most Number of Huons Co., Ltd. (KOSDAQ:243070) Shares?

Feb 02

Could Huons Co., Ltd. (KOSDAQ:243070) Have The Makings Of Another Dividend Aristocrat?

Jan 12

Should You Buy Huons Co., Ltd. (KOSDAQ:243070) For Its Upcoming Dividend?

Dec 25

Update: Huons (KOSDAQ:243070) Stock Gained 28% In The Last Year

Dec 08

Is Huons Co., Ltd.'s (KOSDAQ:243070) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Nov 18

Earnings and Revenue Growth Forecasts

KOSDAQ:A243070 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	747,600	62,200	N/A	70,200	1
12/31/2025	689,800	56,900	N/A	64,600	1
12/31/2024	631,800	51,200	N/A	64,000	1
6/30/2024	580,131	40,150	-13,465	64,826	N/A
3/31/2024	571,848	46,438	3,436	62,075	N/A
12/31/2023	552,007	50,473	7,379	52,143	N/A
9/30/2023	536,097	44,234	-3,095	34,216	N/A
6/30/2023	521,060	34,796	-15,098	20,493	N/A
3/31/2023	504,436	27,631	-7,345	32,198	N/A
12/31/2022	492,387	22,444	-10,181	35,391	N/A
9/30/2022	476,805	17,642	1,768	43,646	N/A
6/30/2022	465,932	29,597	1,711	51,185	N/A
3/31/2022	452,992	30,576	1,852	51,538	N/A
12/31/2021	436,911	30,752	14,456	55,593	N/A
9/30/2021	425,652	54,444	10,975	63,058	N/A
6/30/2021	419,443	53,097	11,279	55,079	N/A
3/31/2021	411,890	54,932	3,576	41,944	N/A
12/31/2020	406,678	55,584	8,277	46,506	N/A
9/30/2020	404,971	42,932	8,886	31,057	N/A
6/30/2020	393,907	40,745	16,471	36,085	N/A
3/31/2020	376,975	38,272	28,772	47,847	N/A
12/31/2019	365,019	38,207	21,386	42,120	N/A
9/30/2019	352,411	40,464	22,018	42,002	N/A
6/30/2019	343,696	43,351	21,469	34,798	N/A
3/31/2019	337,181	45,895	11,934	22,948	N/A
12/31/2018	328,595	45,233	11,446	20,883	N/A
9/30/2018	313,489	41,545	15,832	24,631	N/A
6/30/2018	301,705	37,559	15,662	26,335	N/A
3/31/2018	293,686	34,093	N/A	33,917	N/A
12/31/2017	284,838	35,069	N/A	30,207	N/A
9/30/2017	361,934	37,667	N/A	43,370	N/A
12/31/2016	253,449	23,000	N/A	43,381	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A243070's forecast earnings growth (15.3% per year) is above the savings rate (2.6%).

Earnings vs Market: A243070's earnings (15.3% per year) are forecast to grow slower than the KR market (29.4% per year).

High Growth Earnings: A243070's earnings are forecast to grow, but not significantly.

Revenue vs Market: A243070's revenue (9.8% per year) is forecast to grow slower than the KR market (10% per year).

High Growth Revenue: A243070's revenue (9.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A243070's Return on Equity is forecast to be low in 3 years time (14.2%).

Huons Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Price target decreased to ₩56,000

Price target increased to ₩67,273

Price target raised to ₩75,000

Analysts increase EPS estimates to ₩5,126

Recent updates

Huons Co., Ltd. (KOSDAQ:A243070) agreed to acquire an additional minority stake in PanGen Biotech Inc. (KOSDAQ:A222110) from CG Invites Co., Ltd. (KOSDAQ:A083790) for KRW 9.3 billion

New major risk - Financial data availability

Huons Co., Ltd. (KOSDAQ:A243070) announces an Equity Buyback for KRW 2,000 million worth of its shares.

Huons Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Full year 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ₩330 per share

Third quarter 2023 earnings released: EPS: ₩993 (vs ₩197 in 3Q 2022)

Investor sentiment improves as stock rises 24%

New major risk - Revenue and earnings growth

Investor sentiment improves as stock rises 15%

Upcoming dividend of ₩545 per share

Price target decreased to ₩56,000

Price target increased to ₩67,273

Upcoming dividend of ₩600 per share

First quarter 2021 earnings released: EPS ₩827 (vs ₩881 in 1Q 2020)

Investor sentiment improved over the past week

Here's Why Huons (KOSDAQ:243070) Can Manage Its Debt Responsibly

Investor sentiment improved over the past week

We Think That There Are Issues Underlying Huons' (KOSDAQ:243070) Earnings

Full year 2020 earnings released: EPS ₩5,645 (vs ₩3,872 in FY 2019)

Here's Why We Think Huons (KOSDAQ:243070) Is Well Worth Watching

Price target raised to ₩75,000

New 90-day low: ₩55,400

Is Huons Co., Ltd.'s (KOSDAQ:243070) Recent Performance Tethered To Its Attractive Financial Prospects?

What Type Of Shareholders Own The Most Number of Huons Co., Ltd. (KOSDAQ:243070) Shares?

Could Huons Co., Ltd. (KOSDAQ:243070) Have The Makings Of Another Dividend Aristocrat?

Should You Buy Huons Co., Ltd. (KOSDAQ:243070) For Its Upcoming Dividend?

New 90-day high: ₩68,200

LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd

Update: Huons (KOSDAQ:243070) Stock Gained 28% In The Last Year

Is Huons Co., Ltd.'s (KOSDAQ:243070) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Huons Co., Ltd. announced that it expects to receive KRW 50 billion in funding from a group of investors

New 90-day low: ₩55,200

New 90-day high - ₩70,600

Analysts increase EPS estimates to ₩5,126

New 90-day high - ₩63,400

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies